NCT00004110View on ClinicalTrials.gov

Monoclonal Antibody Therapy Plus Etoposide in Treating Patients With Neuroblastoma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 1999

Primary Completion Date

September 30, 2004

Conditions
Neuroblastoma
Interventions
BIOLOGICAL

monoclonal antibody 3F8

DRUG

etoposide

DRUG

isotretinoin

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00004110 - Monoclonal Antibody Therapy Plus Etoposide in Treating Patients With Neuroblastoma | Biotech Hunter | Biotech Hunter